Arlington Speaks on CIRM's Orphan Software
The head of the Arlington Group, the defunct grant review software firm used by the California stem cell agency, says that CIRM has not acquired the copyright or intellectual property rights to the program used by the agency and other major grant providers.
Earlier, we reported that the San Diego Union-Tribune quoted CIRM President Zach Hall as saying t…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.